Orshe

The FDA is going to monitor pharmaceuticals made in Japan — as well as food products — for any signs of elevated radiation levels, a spokeswoman for the agency tells us.

On Thursday we reported that the FDA would monitor future imports of fish, other food products and raw materials that originate or pass through Japan in transit to the U.S.  Pharmaceutical products will also be monitored, the spokeswoman says.

Any danger to the food supply posed by the ongoing Japanese nuclear power plant crisis would primarily affect people living in that country, since they consume the bulk of local products, the WSJ reports today. (And there is so far no evidence of contamination, the paper says.)

Both surveys show there are big variations in costs for the same procedure, service or drug in the U.S.

Go here to see the original: Two Surveys Spotlight Health-Care Cost Variations

As the WSJ reports, there are 113 suspected cases and one death in the capital.

View post:  Haitian Cholera Outbreak Seems to be Spreading in Port-au-Prince

A solar-powered device made by Omron that costs less than $35 could help people in developing countries accurately track blood pressure.

Continued here:  Study: Solar-Powered Blood-Pressure Device Could Be Valuable

The head of the AMA says doctors need “some stability” so they can continue to take care of Medicare patients.

See the original post here:  AMA Warns of ‘Catastrophe’ Without 13-Month ‘Doc Fix’

Koska’s solution was to come up with a syringe that was impossible to reuse.

See the original post here:  TEDMED: Marc Koska, Preventing Deaths from Reused Syringes

There’s now a total of about 253 deaths and 3,115 cases requiring hospitalization.

Read the original: Cholera in Haiti: Death Toll Exceeds 250 Amidst Efforts to Control Outbreak

A study just published online by the Lancet says that between 125,000 and 277,000 deaths in India each year are due to malaria.

Read the rest here:  Lancet, WHO Disagree on Malaria Death Count in India

Also: food-safety scientists report interference; Berwick speaks; industry-free continuing medical education.

See more here:  A.M. Vitals: Cigna Pushes Overseas, Seeking Growth